Stocks
Blueprint Medicines Corporation (BPMC) Debt/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | |||
| Debt/EBITDA | -4.73 | 1.47 | 1.62 | -0.13 | -7.61 | 3.46 | ||
| Changes by years, y/y, % | -473% | -131% | +10% | -108% | +5 539% | |||
Blueprint Medicines Corporation. Debt/EBITDA
Blueprint Medicines Corporation. Debt/EBITDA, changes, %
Blueprint Medicines Corporation (BPMC) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | LTM ? | |||
| Debt/EBITDA | 0.22 | 0.17 | 4.59 | -7.61 | 3.46 | 3.46 | ||
| Changes by years, y/y, % | -86% | -89% | +215% | +5 238% | +1 455% | |||
| Changes by quarters, q/q, % | -256% | -25% | +2 645% | -266% | -145% | |||
